{
    "organizations": [],
    "uuid": "55e6dd0f51c0d2ad4e1b4459002abc85b15c9ea2",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/01/25/pr-newswire-sensus-healthcare-to-host-fourth-quarter-and-fiscal-year-2017-financial-results-and-business-update-conference-call-on.html",
    "ord_in_thread": 0,
    "title": "Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BOCA RATON, Fla., Jan. 25, 2018 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS) , a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, February 1, 2018 at 4:30 p.m. ET to discuss the financial results for the fourth quarter and year ended December 31, 2017. In addition, management will provide a business update and a discussion on recent and upcoming milestones.\nTo access the conference call, the dial-in numbers are 855-940-9473 (U.S. Toll Free), 412-317-5220 (International), and 855-669-9657 (Canada Toll Free). Please direct the operator to be connected to the Sensus Healthcare call.\nFollowing the conclusion of the conference call, a replay will be available through February 8, 2018 and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 412-317-0088 (International), and 855-669-9658 (Canada Toll Free). All listeners should provide the following replay access code: 10116554. The call will also be archived on the Company's website for a period of time at www.sensushealthcare.com .\nAbout Sensus Healthcare\nSensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://www.sensushealthcare.com .\nContact:\nLHA Investor Relations\nKim Sutton Golodetz\n(212) 838-3777\nkgolodetz@lhai.com\nView original content: http://www.prnewswire.com/news-releases/sensus-healthcare-to-host-fourth-quarter-and-fiscal-year-2017-financial-results-and-business-update-conference-call-on-february-1-2018-300587750.html\nSOURCE Sensus Healthcare",
    "published": "2018-01-25T16:30:00.000+02:00",
    "crawled": "2018-01-25T17:17:59.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "boca",
        "raton",
        "sensus",
        "healthcare",
        "nasdaq",
        "srts",
        "medical",
        "device",
        "company",
        "specializing",
        "treatment",
        "skin",
        "cancer",
        "keloid",
        "superficial",
        "radiation",
        "therapy",
        "srt",
        "announces",
        "management",
        "hold",
        "conference",
        "call",
        "thursday",
        "february",
        "et",
        "discus",
        "financial",
        "result",
        "fourth",
        "quarter",
        "year",
        "ended",
        "december",
        "addition",
        "management",
        "provide",
        "business",
        "update",
        "discussion",
        "recent",
        "upcoming",
        "milestone",
        "access",
        "conference",
        "call",
        "number",
        "toll",
        "free",
        "international",
        "canada",
        "toll",
        "free",
        "please",
        "direct",
        "operator",
        "connected",
        "sensus",
        "healthcare",
        "call",
        "following",
        "conclusion",
        "conference",
        "call",
        "replay",
        "available",
        "february",
        "accessed",
        "dialing",
        "toll",
        "free",
        "international",
        "canada",
        "toll",
        "free",
        "listener",
        "provide",
        "following",
        "replay",
        "access",
        "code",
        "call",
        "also",
        "archived",
        "company",
        "website",
        "period",
        "time",
        "sensus",
        "healthcare",
        "sensus",
        "healthcare",
        "medical",
        "device",
        "company",
        "committed",
        "providing",
        "treatment",
        "skin",
        "cancer",
        "keloid",
        "sensus",
        "us",
        "proprietary",
        "low",
        "energy",
        "technology",
        "known",
        "superficial",
        "radiation",
        "therapy",
        "srt",
        "result",
        "decade",
        "dedicated",
        "research",
        "development",
        "sensus",
        "successfully",
        "incorporated",
        "srt",
        "therapy",
        "portfolio",
        "treatment",
        "device",
        "date",
        "srt",
        "technology",
        "used",
        "effectively",
        "safely",
        "treat",
        "oncological",
        "skin",
        "condition",
        "thousand",
        "patient",
        "information",
        "visit",
        "http",
        "contact",
        "lha",
        "investor",
        "relation",
        "kim",
        "sutton",
        "golodetz",
        "kgolodetz",
        "view",
        "original",
        "content",
        "http",
        "source",
        "sensus",
        "healthcare"
    ]
}